TITLE:
Realtime Data Analytics Fostering Connections at Every Point in the Patient Care Continuum

Polycythemia Vera: Causes, Symptoms, and Treatment Options

GUEST:
Dr. Ellen Ritchie and Finola Hughes

PRESENTER:
Neal Howard

OVERVIEW:
Rare Disease Day is February 28, and in this segment, Dr. Ellen Ritchie, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical College, talks about a rare chronic and underrecognized blood cancer called polycythemia vera (PV), which is part of a group of rare blood cancers known as myeloproliferative neoplasms (MPNs).

For more information about this interview, visit this link:
http://healthprofessionalradio.com.au...

how to treat polycythemia vera starting a new polycythemia vera mpn treatment medicine thrombus in heart portacath removal.

how i treat polycythemia vera alessandro vannucchi, md. elizabeth hexner discusses "masked" polycythemia vera and polycythemia vera "in evolution"...

“masked” polycythemia vera and polycythemia vera “in evolution”.

how to treat polycythemia vera naturally

As recent discoveries have the potential to change the paradigm of how MPN and MDS are diagnosed and treated it is imperative that healthcare professionals who treat these diseases are provided expert review of the most pertinent clinical data pertaining to prognosis diagnosis therapy and disease management and guidance for their optimal integration into everyday clinical practice.

The US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 2015 provides a platform to resolve many of the clinical challenges for diagnosis and treatment through presentations and interactive discussions of the latest clinical and research findings pertaining to MPN and MDS. Topics that will be deliberated include updates in therapeutic interventions of MDS polycythemia vera essential thrombocytopenia and myelofibrosis.

In this presentation Dr. Elizabeth Hexner discusses "masked" polycythemia vera and polycythemia vera "in evolution".